Opportunity Information: Apply for RFA AG 19 002
The Small Research Grant Program for the Next Generation of Clinical Researchers in Alzheimer's Disease (AD) and Alzheimer's Disease Related Dementias (ADRD) Research (R03 Clinical Trial Optional), funding opportunity number RFA-AG-19-002, is a National Institutes of Health (NIH) discretionary grant designed to support early, important, and innovative research projects that address gaps in scientific knowledge related to Alzheimer's disease, related dementias, and healthy brain aging. The main purpose of the program is to encourage and help develop the next generation of U.S.-based clinical and neuroscience researchers by giving them resources to launch or strengthen a research trajectory in AD/ADRD, including work that can improve prevention strategies, diagnostic approaches, treatments, and the quality of care.
This opportunity uses the NIH R03 mechanism, which is typically intended for smaller, focused projects that can be completed with limited resources and within a shorter period compared to larger research grants. The announcement is explicitly labeled "Clinical Trial Optional," meaning applicants may propose studies that include clinical trials, but they are not required to do so. In practice, this allows the program to support a broad range of research designs, from early-stage clinical or translational studies to methods development and other innovative approaches that can quickly produce useful data or proof-of-concept findings in AD/ADRD.
Funding falls under the NIH health research activity category, with CFDA numbers 93.853 and 93.866. The listed award ceiling is $100,000, indicating that proposals are expected to fit within a modest budget appropriate for a small research grant. The notice shows an original closing date of July 3, 2018, and a creation date of April 25, 2018, which reflects the specific published cycle for this particular announcement.
Eligibility is broad and includes many types of U.S. organizations and government entities. Eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; nonprofits both with and without 501(c)(3) IRS status (as long as they are not institutions of higher education, since those are listed separately); for-profit organizations other than small businesses; and small businesses. The program also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions. This emphasis signals an interest in reaching a wide range of institutions, including those that serve historically underrepresented communities, consistent with the goal of expanding and strengthening the future AD/ADRD research workforce.
At the same time, the opportunity places clear restrictions on foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible. In addition, foreign components, as defined in the NIH Grants Policy Statement, are not allowed. In other words, the applicant organization and the project components supported by this award must be domestic, reinforcing the program's stated focus on building the next generation of researchers in the United States.
Overall, this grant opportunity is best understood as a targeted, early-career-friendly funding mechanism meant to spark new lines of AD/ADRD clinical and neuroscience research, generate preliminary data, and help investigators establish themselves in the field. It prioritizes innovative, needed investigations that can move the science forward in practical areas like prevention, diagnosis, treatment, and care, while using a small-grant structure to enable quicker, focused progress and career development for emerging researchers.Apply for RFA AG 19 002
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Small Research Grant Program for the Next Generation of Clinical Researchers in Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD) Research (R03 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853, 93.866.
- This funding opportunity was created on 2018-04-25.
- Applicants must submit their applications by 2018-07-03. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $100,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: America's Marine Highway Program
Previous opportunity: U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 19 002
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 19 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Advancing HIV Therapeutic Vaccine Science (U01 Clinical Trial Required) Apply for RFA AI 18 015 Funding Number: RFA AI 18 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed) Apply for RFA HL 19 023 Funding Number: RFA HL 19 023 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required) Apply for RFA CA 18 026 Funding Number: RFA CA 18 026 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Health Services Research Dissertation Program (R36) Apply for PA 18 765 Funding Number: PA 18 765 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $40,000 |
| Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans (U34 Clinical Trial Not Allowed) Apply for RFA HL 19 027 Funding Number: RFA HL 19 027 Agency: National Institutes of Health Category: Health Funding Amount: $125,000 |
| Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans Resource Access (X01 Clinical Trial Not Allowed) Apply for PAR 18 768 Funding Number: PAR 18 768 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIOSH Occupational Safety and Health Research (R01) Apply for PAR 18 769 Funding Number: PAR 18 769 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed) Apply for PAR 18 772 Funding Number: PAR 18 772 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Genomic Technology Development (R21 Clinical Trial Not Allowed) Apply for PAR 18 778 Funding Number: PAR 18 778 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Novel Genomic Technology Development (R01 Clinical Trial Not Allowed) Apply for PAR 18 777 Funding Number: PAR 18 777 Agency: National Institutes of Health Category: Health Funding Amount: $700,000 |
| NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required) Apply for PAR 18 771 Funding Number: PAR 18 771 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Genomic Technology Development (R43/R44 Clinical Trial Not Allowed) Apply for PAR 18 779 Funding Number: PAR 18 779 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Prevention Technology Transfer Centers Cooperative Agreements (Short Title: PTTC) Apply for SP 19 001 Funding Number: SP 19 001 Agency: Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $7,500,000 |
| NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed) Apply for PAR 18 782 Funding Number: PAR 18 782 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trials Not Allowed) Apply for PAR 18 781 Funding Number: PAR 18 781 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Collaborative Network to Advance Deprescribing Research for Older Adults with Multiple Chronic Conditions (R24 Clinical Trial Optional) Apply for RFA AG 19 005 Funding Number: RFA AG 19 005 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed) Apply for RFA OD 18 005 Funding Number: RFA OD 18 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required) Apply for RFA OD 18 006 Funding Number: RFA OD 18 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Wearable Alcohol Biosensors (SBIR) (R43/R44- Clinical Trial Optional) Apply for PA 18 786 Funding Number: PA 18 786 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Wearable Alcohol Biosensors (STTR) (R41/R42- Clinical Trial Optional) Apply for PA 18 785 Funding Number: PA 18 785 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 19 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.